-
Product Insights
NewIntercellular Adhesion Molecule 1 – Drugs In Development, 2024
The Intercellular Adhesion Molecule 1 pipeline drugs market research report outlays comprehensive information on the Intercellular Adhesion Molecule 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Ophthalmology, and Metabolic Disorders which include indications of Solid Tumor, Mantle Cell Lymphoma, Rheumatoid Arthritis, Inflammation, Ophthalmology, Diabetic Retinopathy, and Niemann-Pick Disease. It also reviews key players involved...
-
Product Insights
NewMucosal Addressin Cell Adhesion Molecule 1 – Drugs In Development, 2024
The Mucosal Addressin Cell Adhesion Molecule 1 pipeline drugs market research report outlays comprehensive information on the Mucosal Addressin Cell Adhesion Molecule 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Immunology, and Metabolic Disorders which include indications of Ulcerative Colitis, Crohn's Disease (Regional Enteritis), Graft Versus Host Disease (GVHD), and Type 1 Diabetes (Juvenile Diabetes)....
-
Product Insights
NewCarcinoembryonic Antigen Related Cell Adhesion Molecule 5 – Drugs In Development, 2024
The Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 pipeline drugs market research report outlays comprehensive information on the Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Metastatic Colorectal Cancer. It also reviews key players involved in Carcinoembryonic Antigen Related Cell Adhesion Molecule...
-
Product Insights
NewCarcinoembryonic Antigen Related Cell Adhesion Molecule 1 – Drugs In Development, 2024
The Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 pipeline drugs market research report outlays comprehensive information on the Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Melanoma. It also reviews key players involved in Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 targeted...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Small Molecule To Agonize Dopamine D1 Receptor For Dementia Associated With Parkinson’s Disease in Dementia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Small Molecule To Agonize Dopamine D1 Receptor For Dementia Associated With Parkinson's Disease in Dementia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Small Molecule To Target PSMA For Metastatic Hormone Refractory Prostate Cancer in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Small Molecule To Target PSMA For Metastatic Hormone Refractory Prostate Cancer in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Small Molecules For Breast Cancer in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Small Molecules For Breast Cancer in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Small Molecules For Breast Cancer in Breast Cancer...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Small Molecule To Antagonize ADORA For Central Nervous System in Narcolepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Small Molecule To Antagonize ADORA For Central Nervous System in Narcolepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Small Molecule To Antagonize ADORA...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Small Molecule To Inhibit CDK9 For HIV Infections And Oncology in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Small Molecule To Inhibit CDK9 For HIV Infections And Oncology in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Small Molecule To Target PSMA For Metastatic Hormone Refractory Prostate Cancer in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Small Molecule To Target PSMA For Metastatic Hormone Refractory Prostate Cancer in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical...